ArticleInternational journal of general medicine2026
A Five-Gene PANoptosis Signature Correlates with Immune Infiltration and Secondary Brain Injury in Intracerebral Hemorrhage.
Article in International journal of general medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Primary intracerebral hemorrhage (ICH) is a severe stroke subtype characterized by high mortality and disability rates, largely attributable to secondary brain injury (SBI). While programmed cell death (PCD) pathways contribute to SBI, their mechanisms remain incompletely understood. This research investigated PANoptosis, a newly defined integrated PCD pathway, and its interactions with immune responses in ICH. Methods: The transcriptomic dataset GSE24265 was analyzed to identify differentially expressed genes (DEGs), which were intersected with a PANoptosis-related gene set. PANoptosis-related DEGs were analyzed through protein-protein interaction (PPI) networks, functional enrichment, and machine learning (LASSO and Random Forest) to identify signature genes. The diagnostic utility was evaluated using nomograms and receiver operating characteristic (ROC) curves. Immune interactions were assessed using CIBERSORT. Key findings were validated in clinical specimens using qRT-PCR and Western blot. Results: We identified 50 PANoptosis-related DEGs in ICH and derived five signature genes (AKR1C2, SLC2A14, FTL, TNFRSF12A, and SLC2A3) that were significantly upregulated and had high diagnostic accuracy. These genes were implicated in an inflammatory cell death hub, as their expression correlated with altered proportions of T follicular helper and T gamma delta cells, linking PANoptosis to immune dysregulation. Experimental validation confirmed the upregulation of mRNA levels of SLC2A3, SLC2A14, and TNFRSF12A in perihematomal tissues, along with increased protein levels of SLC2A3 and SLC2A14. Functional enrichment analysis linked these genes to HIF-1, NF-κB, and TNF signaling pathways in ICH PANoptosis. Conclusion: Our study identifies PANoptosis as a pathological hub connecting SBI and neuroinflammation in ICH, with five signature genes serving as key diagnostic biomarkers. Notably, SLC2A3 was significantly elevated in peripheral blood, highlighting its potential as a non-invasive plasma biomarker for ICH. These genes likely contribute to neuroinflammation through immune crosstalk and metabolic reprogramming, offering novel mechanistic insights and potential therapeutic targets for SBI post-ICH.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.